Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib.

Narayan ShivapurkarEveline E VietschErin CarneyClaudine IsaacsAnton Wellstein

Published in: Clinical and translational medicine (2017)

We conclude that changes in the expression patterns of circulating miRs can be indicators of drug responses that merit prospective studies for validation.

Keyphrases

metastatic breast cancer
poor prognosis
binding protein
case control
emergency department